COVID-19

The Post-covid-19 Condition protocol

Movendo Technology
>
>
The Post-covid-19 Condition protocol

The Post-covid-19 Condition protocol

In concert with its network of national and international clinical partners, Movendo Technology has developed a post-COVID-19 protocol, which has been used since December 2020, consisting of an assessment tool and a specific treatment for neuromotor conditions associated with Post-COVID-19 Condition.

Download the brochure
0mln
Recorded cases of SARS-CoV-2 infection worldwide as of December 2021.1
0%
of patients with a confirmed diagnosis of COVID-19 report still having at least one symptom two weeks after the acute phase.2
0su 5
Patients who tested positive for COVID-19 stated that the symptoms of Post-COVID-19 Condition persisted for more than 5 weeks.
0su 10
Patients who tested positive for COVID-19 stated that the symptoms persisted for more than 12 weeks.3
  1. https://covid19.who.int/
  2. Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al. More than 50 Long-term effects of COVID-19: a systematic review and meta-analysis. medRxiv [Preprint]. 2021. doi:10.1101/2021.01. 27.21250617
  3. Office for National Statistics. The prevalence of long COVID symptoms and COVID-19 complications. [updated December 16, 2020]. Available from: https://www.ons.gov.uk/. Accessed February 2, 2021

What is the Movendo Post-covid-19 Condition protocol?

The application of the dedicated protocol aims to achieve the following objectives:

  1. Focus on the assessment and evolution of the Post-COVID-19 Condition
  2. Early intervention to reduce the persistence of the condition
  3. Acquisition of objective data on the evolution of patients with Post-COVID-19 Condition and subsequent treatment
  4. Integration and efficiency in a single technological assessment and treatment solution

Clinical and robotic assessments
combined in a single analysis

Clinical and robotic assessment parameters are combined to obtain an accurate description of the patient’s condition. The clinical tests available to treating physicians are combined with objective robotic data to form a starting point for the robotic treatment.

CLINICAL ASSESSMENT

ROBOTIC ASSESSMENT

The Post-covid-19 Condition treatment protocol

After the assessment, patients receive personalized robotic treatment using hunova, with exercises tailored to suit their neuromotor deficits. A paper was recently published on the Springer journal “Neurological Science” focusing on the application of hunova for the treatment of post-COVID-19 condition symptoms:

Download the paper

Benefits

  • Sophisticated movement and strength profiles, developed on the basis of the principles of motor learning and brain plasticity during hunova assessment phase, can be applied precisely and repetitively to the customized treatment exercises during the second rehabilitation phase.
  • High-intensity, task-oriented functional training, which is essential for effective, affordable and lasting recovery, to assist therapists in the treatment of patients.
  • Rehabilitation exercises delivered in gaming mode, to provide motivation and support to the patient during the exercises.
  • Treatment tailored to suit the deficits identified.
  • Fully-customizable difficulty levels.
  • Treatment in sitting and standing positions.